vincamine has been researched along with dihydroergotoxine in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (94.12) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elbaum, D; Godoy, E; Nagel, RL; Roth, E | 2 |
Bräuer, H; Klein, M; Szobor, A | 1 |
Cahn, J | 1 |
Boulat, O; Maitre, L; Waldmeier, P | 1 |
Jones, RS; Olpe, HR; Steinmann, MW | 1 |
DeNoble, VJ; Gelpke, LW; Keim, KL; Repetti, SJ; Wood, LM | 1 |
Barzaghi, F; Dragonetti, M; Formento, ML; Gueniau, C; Mantegazza, P; Nencioni, A | 1 |
Barzaghi, F; Boissier, JR; Dragonetti, M; Formento, ML | 1 |
Arrigoni, E; Benzi, G; Curti, D; Dagani, F; Dossena, M; Marzatico, F; Polgatti, M; Raimondo, S; Villa, RF | 1 |
Spagnoli, A; Tognoni, G | 1 |
Branconnier, RJ | 1 |
Arrigoni, E; Benzi, G; Dossena, M; Fulle, D; Pastoris, O; Raimondo, S; Tumminello, MC; Villa, RF | 1 |
Chang, T; Young, RM | 1 |
Cook, P; James, I | 1 |
Olpe, HR; Steinmann, MW | 2 |
3 review(s) available for vincamine and dihydroergotoxine
Article | Year |
---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate Choline; Dementia; Dihydroergotoxine; Humans; Middle Aged; Nafronyl; Pentoxifylline; Piracetam; Vasodilator Agents; Vincamine | 1983 |
The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
Topics: Aged; Brain; Dementia; Dihydroergotoxine; Humans; Meclofenoxate; Nafronyl; Piracetam; Pyrithioxin; Vincamine | 1983 |
Cerebral vasodilators (second of two parts).
Topics: Aged; Animals; Betahistine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Dementia; Dihydroergotoxine; Humans; Isoxsuprine; Nicotinic Acids; Nylidrin; Rats; Receptors, Adrenergic; Receptors, Histamine; Vasodilator Agents; Vincamine | 1981 |
2 trial(s) available for vincamine and dihydroergotoxine
Article | Year |
---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate Choline; Dementia; Dihydroergotoxine; Humans; Middle Aged; Nafronyl; Pentoxifylline; Piracetam; Vasodilator Agents; Vincamine | 1983 |
Cerebral vasodilators (second of two parts).
Topics: Aged; Animals; Betahistine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Dementia; Dihydroergotoxine; Humans; Isoxsuprine; Nicotinic Acids; Nylidrin; Rats; Receptors, Adrenergic; Receptors, Histamine; Vasodilator Agents; Vincamine | 1981 |
14 other study(ies) available for vincamine and dihydroergotoxine
Article | Year |
---|---|
Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
Topics: Anemia, Sickle Cell; Dihydroergotoxine; Drug Evaluation; Humans; Vinca Alkaloids; Vincamine | 1979 |
[Controlled testing of vincamine with special reference to the flow properties of blood].
Topics: Aged; Blood Flow Velocity; Blood Viscosity; Dihydroergotoxine; Drug Evaluation; Drug Tolerance; Hematocrit; Humans; Mental Disorders; Middle Aged; Triglycerides; Vinca Alkaloids; Vincamine | 1979 |
[Pathopharmacologic models of cerebral disorders].
Topics: Aging; Animals; Arteriosclerosis; Cerebrovascular Circulation; Dementia; Dihydroergotoxine; Disease Models, Animal; Dogs; Energy Metabolism; Glucose; Humans; Hypoxia, Brain; Memory; Neurons; Partial Pressure; Rabbits; Vincamine | 1979 |
Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
Topics: Anemia, Sickle Cell; Dihydroergotoxine; Erythrocyte Membrane; Erythrocytes; Humans; Potassium; Vinca Alkaloids; Vincamine | 1978 |
3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: effects of Hydergine and vincamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Cerebellum; Dihydroergotoxine; Dioxanes; Dopamine; Dopamine beta-Hydroxylase; Drug Interactions; Female; Haloperidol; Hippocampus; Idazoxan; Locus Coeruleus; Norepinephrine; Prazosin; Rats; Vincamine | 1990 |
Locus coeruleus as a target for psychogeriatric agents.
Topics: Amphetamine; Animals; Caffeine; Cerebral Cortex; Dihydroergotoxine; Dose-Response Relationship, Drug; Learning; Locus Coeruleus; Male; Memory; Methylphenidate; Neural Pathways; Neurons; Piracetam; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Septum Pellucidum; Vincamine | 1985 |
Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats.
Topics: Animals; Avoidance Learning; Dihydroergotoxine; Hypoxia, Brain; Male; Memory Disorders; Pyrrolidinones; Rats; Rats, Inbred Strains; Reaction Time; Scopolamine; Vinca Alkaloids; Vincamine | 1986 |
A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Dihydroergotoxine; Electroencephalography; Ergolines; Gerbillinae; Male; Mice; Mice, Inbred Strains; Nicergoline; Rats; Rats, Inbred Strains; Vinca Alkaloids; Vincamine | 1986 |
Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.
Topics: Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Dihydroergotoxine; Electroencephalography; Energy Metabolism; Glucose; Glycogen; Lactates; Lactic Acid; Male; Mice; Nicergoline; Phosphocreatine; Rats; Vasodilator Agents; Vinca Alkaloids; Vincamine | 1985 |
Age-dependent modification of drug interference on the enzymatic activities of the rat brain.
Topics: Age Factors; Aging; Animals; Brain; Cytidine Diphosphate Choline; Dihydroergotoxine; Male; Nicergoline; Papaverine; Rats; Suloctidil; Theophylline; Trimetazidine; Vinca Alkaloids; Vincamine | 1980 |
Drug interference on some biochemical parameters of rat cerebral cortex during post-ischemic recovery.
Topics: Alanine; Amino Acids; Animals; Brain Ischemia; Cerebral Cortex; Dihydroergotoxine; Energy Transfer; Glycolysis; Male; Rats; Theophylline; Vincamine | 1980 |
Gas chromatographic assay of pramiracetam in human plasma using nitrogen specific detection.
Topics: Chromatography, Gas; Dihydroergotoxine; Humans; Piracetam; Pyrrolidines; Time Factors; Vincamine | 1983 |
The effect of vincamine, hydergine and piracetam on the firing rate of locus coeruleus neurons.
Topics: Animals; Dihydroergotoxine; Dose-Response Relationship, Drug; Locus Coeruleus; Male; Neurons; Norepinephrine; Piracetam; Pyrrolidinones; Rats; Sleep; Vinca Alkaloids; Vincamine; Wakefulness | 1982 |
Rapid communication the activating activity of vincamine, piracetam, and hydergine on the activity of the noradrenergic neurons of the locus coeruleus.
Topics: Animals; Dihydroergotoxine; Evoked Potentials; Locus Coeruleus; Male; Neurons; Norepinephrine; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Vinca Alkaloids; Vincamine | 1981 |